Display options
Share it on

Asian Pac J Cancer Prev. 2017 May 01;18(5):1233-1236. doi: 10.22034/APJCP.2017.18.5.1233.

Lack of HPV in Benign and Malignant Epithelial Ovarian Tumors in Iran.

Asian Pacific journal of cancer prevention : APJCP

Farah Farzaneh, Seyed Alireza Nadji, Donya Khosravi, Maryam Sadat Hosseini, Mohammad Hashemi Bahremani, Mohammad Chehrazi, Ghazal Bagheri, Afsaneh Sigaroodi, Zahra Haghighatian

Affiliations

  1. 1. Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email: [email protected]

PMID: 28610407 PMCID: PMC5555528 DOI: 10.22034/APJCP.2017.18.5.1233

Abstract

Background: Ovarian epithelial tumors one of the most common gynecological neoplasms; we here evaluated the presence of HPV in benign and malignant examples. Methods: In this cross-sectional study the records of 105 patients with epithelial ovarian tumors (benign and malignant) referred to Imam Hossein University Hospital from 2012 to 2015 were evaluated along with assessment of the presence of the HPV infection using PCR. Results: Among 105 patients, comprising 26 (24.8%) with malignant and 79 (75.2%) with benign lesions, the factors found to impact on malignancy were age at diagnosis, age at first pregnancy, number of pregnancies and hormonal status. However, malignancies was not related to abortion, late menopause, and early menarche. In none of the ovarian tissues (benign and malignant) was HPV DNA found. Conclusion: In this study HPV DNA could not be found in any epithelial ovarian tumors (benign and malignant) removed from 105 women; more studies with larger sample size are needed for a definite conclusion.

Creative Commons Attribution License

Keywords: Epithelial ovarian cancer; human papillomavirus; Neoplasms

References

  1. Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):573-5 - PubMed
  2. Am J Obstet Gynecol. 2010 Jan;202(1):71.e1-6 - PubMed
  3. Br J Cancer. 2003 Aug 18;89(4):672-5 - PubMed
  4. J Pak Med Assoc. 2009 Jan;59(1):18-21 - PubMed
  5. Aust N Z J Obstet Gynaecol. 2005 Jun;45(3):211-4 - PubMed
  6. Int J Gynecol Cancer. 2013 Mar;23(3):437-41 - PubMed
  7. Gynecol Oncol. 1999 Mar;72(3):337-41 - PubMed
  8. Cancer. 2007 Jan 15;109(2):221-7 - PubMed
  9. Fam Pract. 2005 Oct;22(5):548-53 - PubMed
  10. Lancet Oncol. 2010 Aug;11(8):781-9 - PubMed
  11. Taiwan J Obstet Gynecol. 2015 Oct;54(5):559-66 - PubMed
  12. Vaccine. 2006 Aug 31;24 Suppl 3:S3/42-51 - PubMed
  13. J Obstet Gynaecol Res. 2008 Apr;34(2):210-7 - PubMed
  14. J Clin Microbiol. 2004 Jul;42(7):3176-84 - PubMed
  15. J Obstet Gynaecol Res. 2006 Apr;32(2):202-5 - PubMed
  16. Gynecol Oncol. 2016 Mar;140(3):481-5 - PubMed
  17. Lancet Oncol. 2007 Sep;8(9):773-83 - PubMed
  18. JAMA. 2004 Jun 9;291(22):2705-12 - PubMed
  19. Exp Oncol. 2014 Jun;36(2):121-4 - PubMed
  20. Int J Womens Health. 2014 May 23;6:537-45 - PubMed
  21. Nature. 1986 Nov 13-19;324(6093):163-6 - PubMed
  22. Eur J Clin Microbiol Infect Dis. 2012 Sep;31(9):2311-7 - PubMed
  23. Eur J Gynaecol Oncol. 2007;28(5):376-80 - PubMed
  24. Virol J. 2013 Nov 20;10:343 - PubMed
  25. Infect Agent Cancer. 2016 Jul 14;11:39 - PubMed

Publication Types